.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Harvard Business School
Deloitte
US Army
Dow
Accenture
Farmers Insurance
Moodys
Fuji
Cantor Fitzgerald

Generated: June 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077203

« Back to Dashboard
NDA 077203 describes CHOLESTYRAMINE LIGHT, which is a drug marketed by Par Pharm, Teva, Teva Pharms, and Sandoz, and is included in four NDAs. It is available from five suppliers. Additional details are available on the CHOLESTYRAMINE LIGHT profile page.

The generic ingredient in CHOLESTYRAMINE LIGHT is cholestyramine. There are eight drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the cholestyramine profile page.

Summary for NDA: 077203

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 077203

Mechanism of ActionBile-acid Binding Activity

Suppliers and Packaging for NDA: 077203

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CHOLESTYRAMINE LIGHT
cholestyramine
POWDER;ORAL 077203 ANDA Par Pharmaceutical, Inc. 49884-466 49884-466-65 60 PACKET in 1 CARTON (49884-466-65) > 5 g in 1 PACKET (49884-466-63)
CHOLESTYRAMINE LIGHT
cholestyramine
POWDER;ORAL 077203 ANDA Par Pharmaceutical, Inc. 49884-466 49884-466-67 210 g in 1 CAN (49884-466-67)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;ORALStrengthEQ 4GM RESIN/PACKET
Approval Date:Aug 26, 2005TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:POWDER;ORALStrengthEQ 4GM RESIN/SCOOPFUL
Approval Date:Aug 26, 2005TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Dow
Argus Health
Boehringer Ingelheim
Citi
Novartis
US Army
Merck
McKesson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot